Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 50Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia 2

Interventions

Psychiatric Rehabilitation 7Flow Cytometry 6Therapeutics 5Surveys and Questionnaires 5Microarray Analysis 5Gene Expression Profiling 5Vincristine 4Polymerase Chain Reaction 4Methotrexate 4Daunorubicin 4Cytogenetic Analysis 4Amplified Fragment Length Polymorphism Analysis 4ponatinib 3fludarabine 3Watchful Waiting 3Prednisone 3Observation 3Mercaptopurine 3Interviews as Topic 3Inotuzumab Ozogamicin 3Immunologic Techniques 3Immunoenzyme Techniques 3Cytarabine 3Cyclophosphamide 3tisagenlecleucel 2pegaspargase 2fish oil triglycerides 2blinatumomab 2In Situ Hybridization, Fluorescence 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Dasatinib × Clear all
NCT03318770 2022-10-12

Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Gruppo Italiano Malattie EMatologiche dell'Adulto

Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03331211 2017-11-08

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Nanfang Hospital, Southern Medical University

Unknown
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡